Viewing Study NCT05282420


Ignite Creation Date: 2025-12-25 @ 4:10 AM
Ignite Modification Date: 2026-01-15 @ 2:56 PM
Study NCT ID: NCT05282420
Status: UNKNOWN
Last Update Posted: 2022-03-16
First Post: 2022-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ranibizumab Versus Aflibercept for CRVO in Young Patients.
Sponsor: South Valley University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module